These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8549373)

  • 21. [Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology].
    Fujimoto S; Makinoda S; Tanaka T; Ichinohe K
    Jpn J Antibiot; 1985 Dec; 38(12):3513-9. PubMed ID: 3841730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Tack KJ; McGuire NM; Eiseman IA
    Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of Bactrim in gynecology-obstetrics].
    Delacroix P
    Presse Med (1893); 1971 Oct; 79(43):1921. PubMed ID: 5166873
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K; Horiba M; Naide Y; Shinoda M; Hibi H
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Grepafloxacin (Raxar)].
    Friis HM
    Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
    Kuznetsovoĭ SM
    Antibiot Khimioter; 1998; 43(2):40-1. PubMed ID: 9551172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial activity of E-4441, a representative azetidine quinolone.
    Esteve M; Moros M; Coll R; Xicota MA; Llovera S
    Drugs Exp Clin Res; 1990; 16(9):445-9. PubMed ID: 2100245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic study of a new quinolone, DW-116.
    Lee DK
    Drugs; 1995; 49 Suppl 2():323-5. PubMed ID: 8549349
    [No Abstract]   [Full Text] [Related]  

  • 32. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the efficacy and tolerability of mezlocillin in female patients suffering from gynaecological-obstetric infections (author's transl)].
    Weissenbacher ER; Tettenborn D
    Arzneimittelforschung; 1979; 29(12a):1999-2000. PubMed ID: 543911
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of enrofloxacin in chicken.
    Kan CA
    Br Poult Sci; 1997 Dec; 38(5):614. PubMed ID: 9511011
    [No Abstract]   [Full Text] [Related]  

  • 35. Breakpoint determination: rufloxacin.
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
    [No Abstract]   [Full Text] [Related]  

  • 36. [Review [new antimicrobial agent series XLI]: lomefloxacin].
    Soejima R; Matsumoto F
    Jpn J Antibiot; 1991 Oct; 44(10):1045-60. PubMed ID: 1662290
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
    Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T
    Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381
    [No Abstract]   [Full Text] [Related]  

  • 38. [New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics].
    Bondareva NS; Budanov SV
    Antibiot Khimioter; 1998; 43(8):28-33. PubMed ID: 9777103
    [No Abstract]   [Full Text] [Related]  

  • 39. Quinolones in dermatology.
    Sable D; Murakawa GJ
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract]   [Full Text] [Related]  

  • 40. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.